Bayforest Capital Ltd Boosts Position in DaVita Inc. $DVA

Key Points

• Bayforest Capital Ltd increased its holdings in DaVita Inc. by 331.1% during the first quarter, acquiring an additional 2,503 shares and bringing its total to 3,259 shares valued at $499,000.
• Major institutional investors, including Ameriprise Financial and Deutsche Bank, have also adjusted their stakes in DaVita, reflecting continued interest with institutional ownership now at 90.12%.
• Analysts have mixed views on DaVita, with some upgrades and price target changes, culminating in a consensus rating of "Hold" and an average price target of $164.00.

Bayforest Capital Ltd boosted its position in DaVita Inc. (NYSE:DVA - Free Report) by 331.1% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,259 shares of the company's stock after purchasing an additional 2,503 shares during the quarter. Bayforest Capital Ltd's holdings in DaVita were worth $499,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in DVA. Ameriprise Financial Inc. raised its stake in DaVita by 27.2% in the 4th quarter. Ameriprise Financial Inc. now owns 32,545 shares of the company's stock valued at $4,867,000 after purchasing an additional 6,951 shares during the last quarter. Balyasny Asset Management L.P. purchased a new stake in shares of DaVita in the fourth quarter valued at about $322,000. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main purchased a new stake in shares of DaVita in the fourth quarter valued at about $106,000. Deutsche Bank AG grew its holdings in shares of DaVita by 35.2% in the fourth quarter. Deutsche Bank AG now owns 392,422 shares of the company's stock valued at $58,687,000 after purchasing an additional 102,230 shares during the period. Finally, Ethic Inc. grew its holdings in shares of DaVita by 116.7% in the fourth quarter. Ethic Inc. now owns 4,345 shares of the company's stock valued at $650,000 after purchasing an additional 2,340 shares during the period. 90.12% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, insider James O. Hearty sold 2,351 shares of the business's stock in a transaction that occurred on Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total value of $352,650.00. Following the transaction, the insider owned 26,038 shares of the company's stock, valued at approximately $3,905,700. The trade was a 8.28% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 1.50% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the stock. Truist Financial set a $148.00 price objective on shares of DaVita in a report on Friday, August 8th. Wall Street Zen raised shares of DaVita from a "hold" rating to a "buy" rating in a report on Saturday. Bank of America cut their price objective on DaVita from $145.00 to $140.00 and set an "underperform" rating for the company in a research report on Wednesday, September 10th. Finally, Barclays decreased their target price on shares of DaVita from $169.00 to $160.00 and set an "equal weight" rating on the stock in a research report on Thursday, August 7th. Three investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Reduce" and a consensus price target of $158.00.

DaVita Stock Performance

NYSE DVA traded down $1.77 on Monday, reaching $131.41. The stock had a trading volume of 187,533 shares, compared to its average volume of 845,408. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.34 and a current ratio of 1.39. DaVita Inc. has a 12-month low of $126.07 and a 12-month high of $179.60. The business's 50-day moving average price is $138.45 and its 200 day moving average price is $141.47. The stock has a market cap of $9.40 billion, a P/E ratio of 12.91, a price-to-earnings-growth ratio of 0.95 and a beta of 1.13.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $2.95 earnings per share for the quarter, beating analysts' consensus estimates of $2.70 by $0.25. The company had revenue of $3.38 billion during the quarter, compared to analysts' expectations of $3.36 billion. DaVita had a return on equity of 369.39% and a net margin of 6.35%.The firm's revenue for the quarter was up 6.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.00 earnings per share. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. As a group, equities analysts expect that DaVita Inc. will post 10.76 earnings per share for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.